Avanza Fonder’s Health Catalyst HCAT Stock Holding History

Avanza Fonder’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,050	Closed	-$33.1K	–	476
2026 Q1	$33.1K	Hold	26,050	–	–	﹤0.01%	481
2025 Q4	$62.3K	Hold	26,050	–	–	﹤0.01%	487
2025 Q3	$74.2K	Hold	26,050	–	–	﹤0.01%	421
2025 Q2	$98.2K	Hold	26,050	–	–	﹤0.01%	412
2025 Q1	$116K	Hold	26,050	–	–	﹤0.01%	429
2024 Q4	$184K	Buy	+26,050	New	+$207K	0.01%	399

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Avanza Fonder's HCAT Position: Q2 2026 in Review

Avanza Fonder sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 26,050 shares — an estimated $33.1K sold.

Avanza Fonder first reported a position in HCAT in Q4 2024 and held it in 6 quarters. The position peaked at $184K in Q4 2024. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

Avanza Fonder reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
Avanza Fonder sold 26,050 Health Catalyst shares in Q2 2026, an estimated $33.1K.
Avanza Fonder first reported a position in Health Catalyst in Q4 2024 and held it in 6 quarters.
Avanza Fonder's Health Catalyst position peaked at $184K in Q4 2024.
126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.